A Prospective, Open Phase I Study to Investigate the Tolerability and Efficacy of Administering ALECSAT to Prostate Cancer Patients - a First Dose in Man Study.
Phase of Trial: Phase I
Latest Information Update: 26 Apr 2012
At a glance
- Drugs Cancer vaccine-ALECSAT (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 26 Apr 2012 Actual patient number 13 added as reported by ClinicalTrials.gov.
- 29 Aug 2011 New trial record